UY29077A1 - Amidas sustituidas de ácido tienopirrolcarboxílico, amidas del ácido pirrolotiazolcarboxílico y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon) - Google Patents

Amidas sustituidas de ácido tienopirrolcarboxílico, amidas del ácido pirrolotiazolcarboxílico y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon)

Info

Publication number
UY29077A1
UY29077A1 UY29077A UY29077A UY29077A1 UY 29077 A1 UY29077 A1 UY 29077A1 UY 29077 A UY29077 A UY 29077A UY 29077 A UY29077 A UY 29077A UY 29077 A1 UY29077 A1 UY 29077A1
Authority
UY
Uruguay
Prior art keywords
acid
epsilon
inhibitors
formula
tienopirrolcarboxyl
Prior art date
Application number
UY29077A
Other languages
English (en)
Spanish (es)
Inventor
Fink David Marc
Chiang Yulin
Collar Nicola Dawn
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of UY29077A1 publication Critical patent/UY29077A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
UY29077A 2004-08-19 2005-08-19 Amidas sustituidas de ácido tienopirrolcarboxílico, amidas del ácido pirrolotiazolcarboxílico y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon) UY29077A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60334704P 2004-08-19 2004-08-19

Publications (1)

Publication Number Publication Date
UY29077A1 true UY29077A1 (es) 2006-03-31

Family

ID=35695546

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29077A UY29077A1 (es) 2004-08-19 2005-08-19 Amidas sustituidas de ácido tienopirrolcarboxílico, amidas del ácido pirrolotiazolcarboxílico y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon)

Country Status (30)

Country Link
US (2) US7393867B2 (enExample)
EP (1) EP1784409B1 (enExample)
JP (1) JP4869232B2 (enExample)
KR (1) KR20070045263A (enExample)
CN (1) CN100562521C (enExample)
AR (1) AR051008A1 (enExample)
AT (1) ATE471326T1 (enExample)
AU (1) AU2005272584B2 (enExample)
BR (1) BRPI0514419A (enExample)
CA (1) CA2577879C (enExample)
CY (1) CY1110775T1 (enExample)
DE (1) DE602005021889D1 (enExample)
DK (1) DK1784409T3 (enExample)
ES (1) ES2347166T3 (enExample)
GT (1) GT200500215A (enExample)
HR (1) HRP20100475T1 (enExample)
IL (1) IL181158A0 (enExample)
JO (1) JO2629B1 (enExample)
MY (1) MY139831A (enExample)
PA (1) PA8642801A1 (enExample)
PE (1) PE20060630A1 (enExample)
PL (1) PL1784409T3 (enExample)
PT (1) PT1784409E (enExample)
RS (1) RS51413B (enExample)
RU (1) RU2403257C2 (enExample)
SI (1) SI1784409T1 (enExample)
SV (1) SV2006002190A (enExample)
TW (1) TWI372149B (enExample)
UY (1) UY29077A1 (enExample)
WO (1) WO2006021000A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004312530A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
CA2636324C (en) 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
EP1955699A1 (en) * 2007-02-08 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Use of flibanserin for the treatment of insomnia
JP5420534B2 (ja) 2007-05-31 2014-02-19 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
EP2397481B1 (en) * 2009-02-12 2014-03-12 Pharmadesign, Inc. Inhibitor of casein kinase 1delta and casein kinase 1epsilon
EP2435443B1 (en) * 2009-05-28 2013-07-31 Vertex Pharmaceuticals Incorporated Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
HRP20140252T1 (hr) * 2009-10-28 2014-04-25 Pfizer Inc. Derivati imidazola kao inhibitori kazeinske kinaze
DE102009058280A1 (de) * 2009-12-14 2011-06-16 Merck Patent Gmbh Thiazolderivate
RU2562833C2 (ru) 2010-08-09 2015-09-10 НБ Хелс Лаборатори Ко. Лтд. Ингибитор казеинкиназы 1 дельта и казеинкиназы 1 е
CN109748927A (zh) * 2017-11-03 2019-05-14 上海交通大学医学院附属瑞金医院 杂芳基酰胺类化合物、其制备方法、药用组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702001D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
WO2000075669A1 (en) * 1999-06-08 2000-12-14 Aventis Pharmaceuticals Inc. Screening methods for altering circadian rhythm proteins
AU2004303826A1 (en) * 2003-12-11 2005-07-07 Aventis Pharmaceuticals Inc. Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase I Epsilon

Also Published As

Publication number Publication date
CY1110775T1 (el) 2015-06-10
TW200621788A (en) 2006-07-01
GT200500215A (es) 2006-03-27
DK1784409T3 (da) 2010-09-27
PE20060630A1 (es) 2006-08-03
HK1105198A1 (en) 2008-02-06
JP2008510712A (ja) 2008-04-10
EP1784409B1 (en) 2010-06-16
EP1784409A2 (en) 2007-05-16
CA2577879A1 (en) 2006-02-23
AU2005272584B2 (en) 2010-11-11
BRPI0514419A (pt) 2008-06-10
TWI372149B (en) 2012-09-11
PA8642801A1 (es) 2006-05-16
KR20070045263A (ko) 2007-05-02
US20070299112A1 (en) 2007-12-27
HRP20100475T1 (hr) 2010-10-31
JP4869232B2 (ja) 2012-02-08
JO2629B1 (en) 2012-06-24
PL1784409T3 (pl) 2010-10-29
US7393867B2 (en) 2008-07-01
SI1784409T1 (sl) 2010-10-29
ATE471326T1 (de) 2010-07-15
RU2403257C2 (ru) 2010-11-10
AU2005272584A1 (en) 2006-02-23
CN101001861A (zh) 2007-07-18
RU2007109812A (ru) 2008-09-27
SV2006002190A (es) 2006-05-24
IL181158A0 (en) 2007-07-04
US7652046B2 (en) 2010-01-26
CA2577879C (en) 2011-07-12
CN100562521C (zh) 2009-11-25
WO2006021000A3 (en) 2006-06-15
RS51413B (sr) 2011-02-28
MY139831A (en) 2009-10-30
DE602005021889D1 (en) 2010-07-29
WO2006021000A2 (en) 2006-02-23
PT1784409E (pt) 2010-09-06
US20080227822A1 (en) 2008-09-18
AR051008A1 (es) 2006-12-13
ES2347166T3 (es) 2010-10-26

Similar Documents

Publication Publication Date Title
UY29077A1 (es) Amidas sustituidas de ácido tienopirrolcarboxílico, amidas del ácido pirrolotiazolcarboxílico y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon)
BRPI0513915A (pt) compostos aminoeteroarila enantiomericamente puros como inibidores de proteìna quinase
EA200801551A1 (ru) Применение сульфонамидных производных в лечении расстройств метаболизма и нервной системы
EA201001188A1 (ru) Связанные мостиковой связью бициклические гетероциклические или спиробициклические гетероциклические производные пиразоло[1,5-a]пиримидинов, способы их получения и их применения
CY1108230T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
PE20050255A1 (es) Nuevas cianotiazolidas y procedimiento para su preparacion como medicamentos
HRP20050059B1 (hr) Novi inhibitori kinaza
EA201200952A1 (ru) Производные пиразина и их применение для лечения неврологических нарушений
BRPI0514537B8 (pt) compostos de aminoeteroarila substituídos com pirazol e composição farmacêutica que os compreende
ECSP088121A (es) Derivados de pirrolo [2,3-b] piridina comoinhibidores de proteina cinasa
MX2010007714A (es) Piridinas fusionadas activas como inhibidores de c-met.
ECSP099051A (es) Inhibidores de tirosina quinasa
ECSP077277A (es) Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas
EA201490630A1 (ru) 6-замещенные 3-(хинолин-6-илтио)[1,2,4]триазоло[4,3-a]пиридины в качестве ингибиторов c-met тирозинкиназы
NO20080393L (no) Halogenerte pyrazolo [1,5-A] pyrimidiner, fremgangsmater, anvendelse som GABA-A reseptorligander, sammensetninger og intermediater
ATE439831T1 (de) Stabile kristalline form von bifeprunoxmesylat, dosierungsformen davon und verfahren zu deren verwendung
ATE438617T1 (de) Substituierte cyclohexyl-1,4-diamin-derivate
UY29078A1 (es) Amidas del ácido 5 y 6-aminoalquil indol-2-carboxílico 3-sustituidas y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon)
CY1110087T1 (el) Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο
NO20090972L (no) Pyrazolo[1,5-A]pyrimidiner, fremgangsmater, anvendelser og sammensetninger
EA200701758A1 (ru) Замещённые арильные производные 1,4-пиразина
DOP2005000158A (es) Amidas sustituidas de acido tienopirrolcarboxilico, amidas del acido pirrolotiazolcarbonoxilio, y analogos relacionados como inhibidores de la caseina cinasa i
ECSP066555A (es) Derivados de morfolina como inhibidores de la reabsorcion de norepinefrina
UY30066A1 (es) Hidrazidas del acido imidazo(1,2-a) piridin-3-il-acético, procesos, usos y composiciones
DOP2005000157A (es) Amidas del acido 5 y 6-aminoalquil indol-2-carboxilico 3-sustituidas y analogos relacionados como inhibidores de la caseina cinasa 1

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160809